Long Ideas - Questcor Pharmaceuticals (NASDAQ:QCOR) is scheduled to report third quarter earnings Tuesday after the market closes, and the Wall Street Consensus expects revenues (mostly Acthar Gel) … Continue Reading
Read nowLong Ideas - Canadian-based Nuvo Research (TSE:NRI) announced Monday morning that the FDA has approved its Pliaglis product, a unique local anesthetic designed to minimize pain during aesthetic … Continue Reading
Read nowResearch - We continue to believe that shares of Elan Corp. (NYSE:ELN) are trading at a premium valuation, given ongoing speculation that partner Biogen-Idec (NASDAQ:BIIB) may acquire … Continue Reading
Read nowMost Popular - Shares of Amarin, plc (NASDAQ:AMRN) were highly volatile in early afternoon trading Thursday as an article written in the P&T Journal, published on a National … Continue Reading
Read nowLong Ideas - After being decimated earlier this year on the FDA rejection of Northera, shares of Chelsea Therapeutics (NASDAQ:CHTP) could be rejuvenated as new Phase III results … Continue Reading
Read now- We have written about the pressure on shares of Elan Corp. (NYSE:ELN), which has been taking place in advance of the expected market entry of … Continue Reading
Read now- In a move of self-preservation, Peregrine Pharmaceuticals (NASDAQ:PPHM) announced Wednesday that it raised $14.3 million in gross proceeds through an ATM (At The Market) agreement … Continue Reading
Read now